Filing Flows › Teva Pharmaceutical Industries (TEVA) › Q2 2025
Teva Pharmaceutical Industries (TEVA) Q2 2025 earnings results (second quarter 2025)
10-Q filed Jul 30, 2025
Teva Pharmaceutical Industries (TEVA) reported revenue of $4.2B for the second quarter 2025 (Q2 2025), +0.3% from a year earlier and +7% from the quarter before. Operating margin was 10.9%, net earnings $282M (6.8% of revenue).
Teva Pharmaceutical Industries, Q2 2025: revenue $4.2B (+0.3% year over year), operating margin 10.9%, net earnings $282M, operating cash flow $227M. The chart follows the revenue to costs, profit and cash.
| Q2 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $4.2B | +7% | +0.3% |
| Gross profit | $2.1B | +12% | +4% |
| Operating profit | $455M | -12% | — |
| Net earnings | $282M | +32% | — |
| Operating cash flow | $227M | — | +120% |
| Free cash flow | $131M | — | 22× |
What changed
Revenue was $4.2B in Q2 2025, roughly flat year over year and up 7% from the previous quarter. Product was the largest line at 87% of revenue. Product and Service Other added $0.01B year over year (up 10%), 92% of the total change. Distribution Service declined 1%.
Gross margin was 50.3%, up 1.7 points from a year earlier. Operating profit was $0.46B, a 10.9% margin (up 11.0 points year over year). Operating expenses fell 19% while revenue was flat. Net earnings were $0.28B. The effective tax rate was -38.0%.
Operating cash flow was $0.23B (up 120% year over year), 80% of net earnings. Non-cash charges added back $0.25B of depreciation and amortization and $0.04B of share-based compensation. Working capital and other items used $0.34B. Capital expenditures of $0.10B left free cash flow of $0.13B.
Questions
What was Teva Pharmaceutical Industries' revenue in the second quarter 2025?
Teva Pharmaceutical Industries (TEVA) reported revenue of $4.2B for the second quarter 2025 (Q2 2025), +0.3% from a year earlier and +7% from the quarter before.
Was Teva Pharmaceutical Industries profitable in the second quarter 2025?
Operating profit was $455M (10.9% of revenue) and net earnings $282M.